Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Leases (2019 - 2025)

STRATA Skin Sciences' Operating Leases history spans 7 years, with the latest figure at $688000.0 for Q4 2025.

  • On a quarterly basis, Operating Leases fell 25.14% to $688000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $688000.0, a 25.14% decrease, with the full-year FY2025 number at $688000.0, down 25.14% from a year prior.
  • Operating Leases hit $688000.0 in Q4 2025 for STRATA Skin Sciences, down from $736000.0 in the prior quarter.
  • Over the last five years, Operating Leases for SSKN hit a ceiling of $1.2 million in Q1 2024 and a floor of $237000.0 in Q4 2023.
  • Historically, Operating Leases has averaged $638350.0 across 5 years, with a median of $611500.0 in 2021.
  • Biggest five-year swings in Operating Leases: plummeted 61.15% in 2023 and later soared 287.76% in 2024.
  • Tracing SSKN's Operating Leases over 5 years: stood at $392000.0 in 2021, then soared by 55.61% to $610000.0 in 2022, then plummeted by 61.15% to $237000.0 in 2023, then soared by 287.76% to $919000.0 in 2024, then dropped by 25.14% to $688000.0 in 2025.
  • Business Quant data shows Operating Leases for SSKN at $688000.0 in Q4 2025, $736000.0 in Q3 2025, and $1.1 million in Q2 2025.